Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer.

Cancer biomarkers : section A of Disease markers - 12 Dec 2017

Yang Ching-Yao, Lin Mong-Wei, Chang Yih-Leong, Wu Chen-Tu

Abstract excerpt

BACKGROUND: Globo H is a tumor-associated carbohydrate antigen exclusively expressed in cancer cells rather than normal tissue. Globo H has been found on many cancers of epithelial origins, and become an attractive target for cancer vaccine. OBJECTIVES: We aimed to study the expression of Globo H in non-small cell lung cancer (NSCLC) patients, and correlated its expression with common driver mutations, clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Tumor-Associated, Carbohydrate
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to Kaplan-Meier Estimate

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 29036791
DOI: 10.3233/CBM-170660
PMCID: PMC13075751

Genes

EGFR
ALK
BRAF
FGFR1
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer.PMID 29036791Read ↗

A molecularly engineered lectin destroys EGFR and inhibits the growth of non-small cell lung cancerSemantic proximity Read ↗

Small Cell Lung Cancer Neuroendocrine Subtypes are Associated with Different Immune Microenvironment and Checkpoint Molecule DistributionSemantic proximity Read ↗

B7-H4 and HHLA2, members of B7 family, are aberrantly expressed in EGFR mutated lung adenocarcinoma.Semantic proximity Read ↗

HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status.Semantic proximity Read ↗

Comprehensive analyses of Disulfidptosis-related genes on prognosis and immune infiltration in lung adenocarcinomaSemantic proximity Read ↗

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacySemantic proximity Read ↗

Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.